Mizuho raises Cigna Group price target to $340
Mizuho analyst Ann Hynes maintained an Outperform rating on Cigna Group and raised the price target to $340 from $330, signaling confidence in the stock's future performance.
*this image is generated using AI for illustrative purposes only.
Mizuho analyst Ann Hynes has maintained an Outperform rating on Cigna Group, raising the price target to $340 from the previous $330. The adjustment reflects a revised outlook on the healthcare company's stock performance.
Rating and Price Target
The research note highlights the continued confidence in Cigna Group's prospects. Below are the key details from the filing:
| Metric | Value |
|---|---|
| Rating | Outperform |
| Previous Price Target | $330 |
| New Price Target | $340 |
The upward revision in the price target suggests an expectation of positive momentum in the stock's value.
What specific factors drove Mizuho to revise Cigna's price target upward at this time?
How might Cigna's recent performance compare to its competitors in the healthcare sector?
What are the potential risks that could hinder Cigna from reaching the new $340 price target?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
